1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Therapeutic Proteins
        1.2.4 Vaccines
    1.3 Market by Application
        1.3.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Endocrinology
        1.3.3 Immunology
        1.3.4 Hematology
        1.3.5 Infectiology
        1.3.6 Neurology
        1.3.7 Oncology
        1.3.8 Genetic Disorder
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Drugs of Bioengineered Protein Market Perspective (2017-2028)
    2.2 Drugs of Bioengineered Protein Growth Trends by Region
        2.2.1 Drugs of Bioengineered Protein Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Drugs of Bioengineered Protein Historic Market Size by Region (2017-2022)
        2.2.3 Drugs of Bioengineered Protein Forecasted Market Size by Region (2023-2028)
    2.3 Drugs of Bioengineered Protein Market Dynamics
        2.3.1 Drugs of Bioengineered Protein Industry Trends
        2.3.2 Drugs of Bioengineered Protein Market Drivers
        2.3.3 Drugs of Bioengineered Protein Market Challenges
        2.3.4 Drugs of Bioengineered Protein Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Drugs of Bioengineered Protein Players by Revenue
        3.1.1 Global Top Drugs of Bioengineered Protein Players by Revenue (2017-2022)
        3.1.2 Global Drugs of Bioengineered Protein Revenue Market Share by Players (2017-2022)
    3.2 Global Drugs of Bioengineered Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drugs of Bioengineered Protein Revenue
    3.4 Global Drugs of Bioengineered Protein Market Concentration Ratio
        3.4.1 Global Drugs of Bioengineered Protein Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drugs of Bioengineered Protein Revenue in 2021
    3.5 Drugs of Bioengineered Protein Key Players Head office and Area Served
    3.6 Key Players Drugs of Bioengineered Protein Product Solution and Service
    3.7 Date of Enter into Drugs of Bioengineered Protein Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs of Bioengineered Protein Breakdown Data by Type
    4.1 Global Drugs of Bioengineered Protein Historic Market Size by Type (2017-2022)
    4.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2023-2028)
5 Drugs of Bioengineered Protein Breakdown Data by Application
    5.1 Global Drugs of Bioengineered Protein Historic Market Size by Application (2017-2022)
    5.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Drugs of Bioengineered Protein Market Size (2017-2028)
    6.2 North America Drugs of Bioengineered Protein Market Size by Type
        6.2.1 North America Drugs of Bioengineered Protein Market Size by Type (2017-2022)
        6.2.2 North America Drugs of Bioengineered Protein Market Size by Type (2023-2028)
        6.2.3 North America Drugs of Bioengineered Protein Market Share by Type (2017-2028)
    6.3 North America Drugs of Bioengineered Protein Market Size by Application
        6.3.1 North America Drugs of Bioengineered Protein Market Size by Application (2017-2022)
        6.3.2 North America Drugs of Bioengineered Protein Market Size by Application (2023-2028)
        6.3.3 North America Drugs of Bioengineered Protein Market Share by Application (2017-2028)
    6.4 North America Drugs of Bioengineered Protein Market Size by Country
        6.4.1 North America Drugs of Bioengineered Protein Market Size by Country (2017-2022)
        6.4.2 North America Drugs of Bioengineered Protein Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Drugs of Bioengineered Protein Market Size (2017-2028)
    7.2 Europe Drugs of Bioengineered Protein Market Size by Type
        7.2.1 Europe Drugs of Bioengineered Protein Market Size by Type (2017-2022)
        7.2.2 Europe Drugs of Bioengineered Protein Market Size by Type (2023-2028)
        7.2.3 Europe Drugs of Bioengineered Protein Market Share by Type (2017-2028)
    7.3 Europe Drugs of Bioengineered Protein Market Size by Application
        7.3.1 Europe Drugs of Bioengineered Protein Market Size by Application (2017-2022)
        7.3.2 Europe Drugs of Bioengineered Protein Market Size by Application (2023-2028)
        7.3.3 Europe Drugs of Bioengineered Protein Market Share by Application (2017-2028)
    7.4 Europe Drugs of Bioengineered Protein Market Size by Country
        7.4.1 Europe Drugs of Bioengineered Protein Market Size by Country (2017-2022)
        7.4.2 Europe Drugs of Bioengineered Protein Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Drugs of Bioengineered Protein Market Size (2017-2028)
    8.2 Asia-Pacific Drugs of Bioengineered Protein Market Size by Type
        8.2.1 Asia-Pacific Drugs of Bioengineered Protein Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Drugs of Bioengineered Protein Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Drugs of Bioengineered Protein Market Share by Type (2017-2028)
    8.3 Asia-Pacific Drugs of Bioengineered Protein Market Size by Application
        8.3.1 Asia-Pacific Drugs of Bioengineered Protein Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Drugs of Bioengineered Protein Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Drugs of Bioengineered Protein Market Share by Application (2017-2028)
    8.4 Asia-Pacific Drugs of Bioengineered Protein Market Size by Region
        8.4.1 Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Drugs of Bioengineered Protein Market Size (2017-2028)
    9.2 Latin America Drugs of Bioengineered Protein Market Size by Type
        9.2.1 Latin America Drugs of Bioengineered Protein Market Size by Type (2017-2022)
        9.2.2 Latin America Drugs of Bioengineered Protein Market Size by Type (2023-2028)
        9.2.3 Latin America Drugs of Bioengineered Protein Market Share by Type (2017-2028)
    9.3 Latin America Drugs of Bioengineered Protein Market Size by Application
        9.3.1 Latin America Drugs of Bioengineered Protein Market Size by Application (2017-2022)
        9.3.2 Latin America Drugs of Bioengineered Protein Market Size by Application (2023-2028)
        9.3.3 Latin America Drugs of Bioengineered Protein Market Share by Application (2017-2028)
    9.4 Latin America Drugs of Bioengineered Protein Market Size by Country
        9.4.1 Latin America Drugs of Bioengineered Protein Market Size by Country (2017-2022)
        9.4.2 Latin America Drugs of Bioengineered Protein Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Drugs of Bioengineered Protein Market Size (2017-2028)
    10.2 Middle East & Africa Drugs of Bioengineered Protein Market Size by Type
        10.2.1 Middle East & Africa Drugs of Bioengineered Protein Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Drugs of Bioengineered Protein Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Drugs of Bioengineered Protein Market Share by Type (2017-2028)
    10.3 Middle East & Africa Drugs of Bioengineered Protein Market Size by Application
        10.3.1 Middle East & Africa Drugs of Bioengineered Protein Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Drugs of Bioengineered Protein Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Drugs of Bioengineered Protein Market Share by Application (2017-2028)
    10.4 Middle East & Africa Drugs of Bioengineered Protein Market Size by Country
        10.4.1 Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Introduction
        11.1.4 GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Drugs of Bioengineered Protein Introduction
        11.2.4 Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Drugs of Bioengineered Protein Introduction
        11.3.4 Merck Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Drugs of Bioengineered Protein Introduction
        11.4.4 Novartis Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Company Details
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Drugs of Bioengineered Protein Introduction
        11.5.4 Sanofi Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.5.5 Sanofi Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Drugs of Bioengineered Protein Introduction
        11.6.4 Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.6.5 Eli Lilly Recent Developments
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Roche Business Overview
        11.7.3 Roche Drugs of Bioengineered Protein Introduction
        11.7.4 Roche Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.7.5 Roche Recent Developments
    11.8 Dr. Reddy's Laboratories
        11.8.1 Dr. Reddy's Laboratories Company Details
        11.8.2 Dr. Reddy's Laboratories Business Overview
        11.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Introduction
        11.8.4 Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.8.5 Dr. Reddy's Laboratories Recent Developments
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Company Details
        11.9.2 Abbott Laboratories Business Overview
        11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Introduction
        11.9.4 Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.9.5 Abbott Laboratories Recent Developments
    11.10 Amgen
        11.10.1 Amgen Company Details
        11.10.2 Amgen Business Overview
        11.10.3 Amgen Drugs of Bioengineered Protein Introduction
        11.10.4 Amgen Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.10.5 Amgen Recent Developments
    11.11 Bayer AG
        11.11.1 Bayer AG Company Details
        11.11.2 Bayer AG Business Overview
        11.11.3 Bayer AG Drugs of Bioengineered Protein Introduction
        11.11.4 Bayer AG Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.11.5 Bayer AG Recent Developments
    11.12 Biocon
        11.12.1 Biocon Company Details
        11.12.2 Biocon Business Overview
        11.12.3 Biocon Drugs of Bioengineered Protein Introduction
        11.12.4 Biocon Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.12.5 Biocon Recent Developments
    11.13 Fresenius kabi
        11.13.1 Fresenius kabi Company Details
        11.13.2 Fresenius kabi Business Overview
        11.13.3 Fresenius kabi Drugs of Bioengineered Protein Introduction
        11.13.4 Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.13.5 Fresenius kabi Recent Developments
    11.14 Panacea Biotec
        11.14.1 Panacea Biotec Company Details
        11.14.2 Panacea Biotec Business Overview
        11.14.3 Panacea Biotec Drugs of Bioengineered Protein Introduction
        11.14.4 Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2017-2022)
        11.14.5 Panacea Biotec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Therapeutic Proteins
    Table 4. Key Players of Vaccines
    Table 5. Global Drugs of Bioengineered Protein Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Drugs of Bioengineered Protein Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Drugs of Bioengineered Protein Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Drugs of Bioengineered Protein Market Share by Region (2017-2022)
    Table 9. Global Drugs of Bioengineered Protein Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Drugs of Bioengineered Protein Market Share by Region (2023-2028)
    Table 11. Drugs of Bioengineered Protein Market Trends
    Table 12. Drugs of Bioengineered Protein Market Drivers
    Table 13. Drugs of Bioengineered Protein Market Challenges
    Table 14. Drugs of Bioengineered Protein Market Restraints
    Table 15. Global Drugs of Bioengineered Protein Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Drugs of Bioengineered Protein Revenue Share by Players (2017-2022)
    Table 17. Global Top Drugs of Bioengineered Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2021)
    Table 18. Ranking of Global Top Drugs of Bioengineered Protein Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Drugs of Bioengineered Protein Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Drugs of Bioengineered Protein Product Solution and Service
    Table 22. Date of Enter into Drugs of Bioengineered Protein Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2017-2022)
    Table 26. Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2023-2028)
    Table 28. Global Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Drugs of Bioengineered Protein Revenue Share by Application (2017-2022)
    Table 30. Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Drugs of Bioengineered Protein Revenue Share by Application (2023-2028)
    Table 32. North America Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Drugs of Bioengineered Protein Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Drugs of Bioengineered Protein Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Drugs of Bioengineered Protein Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Drugs of Bioengineered Protein Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Drugs of Bioengineered Protein Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Drugs of Bioengineered Protein Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Drugs of Bioengineered Protein Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Drugs of Bioengineered Protein Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Drugs of Bioengineered Protein Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Drugs of Bioengineered Protein Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Drugs of Bioengineered Protein Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Drugs of Bioengineered Protein Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Drugs of Bioengineered Protein Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Drugs of Bioengineered Protein Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Drugs of Bioengineered Protein Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Drugs of Bioengineered Protein Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Drugs of Bioengineered Protein Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Drugs of Bioengineered Protein Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Drugs of Bioengineered Protein Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Drugs of Bioengineered Protein Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Drugs of Bioengineered Protein Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Drugs of Bioengineered Protein Market Size by Country (2023-2028) & (US$ Million)
    Table 62. GlaxoSmithKline Company Details
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline Drugs of Bioengineered Protein Product
    Table 65. GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Developments
    Table 67. Johnson & Johnson Company Details
    Table 68. Johnson & Johnson Business Overview
    Table 69. Johnson & Johnson Drugs of Bioengineered Protein Product
    Table 70. Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 71. Johnson & Johnson Recent Developments
    Table 72. Merck Company Details
    Table 73. Merck Business Overview
    Table 74. Merck Drugs of Bioengineered Protein Product
    Table 75. Merck Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 76. Merck Recent Developments
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Drugs of Bioengineered Protein Product
    Table 80. Novartis Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 81. Novartis Recent Developments
    Table 82. Sanofi Company Details
    Table 83. Sanofi Business Overview
    Table 84. Sanofi Drugs of Bioengineered Protein Product
    Table 85. Sanofi Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 86. Sanofi Recent Developments
    Table 87. Eli Lilly Company Details
    Table 88. Eli Lilly Business Overview
    Table 89. Eli Lilly Drugs of Bioengineered Protein Product
    Table 90. Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 91. Eli Lilly Recent Developments
    Table 92. Roche Company Details
    Table 93. Roche Business Overview
    Table 94. Roche Drugs of Bioengineered Protein Product
    Table 95. Roche Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 96. Roche Recent Developments
    Table 97. Dr. Reddy's Laboratories Company Details
    Table 98. Dr. Reddy's Laboratories Business Overview
    Table 99. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product
    Table 100. Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 101. Dr. Reddy's Laboratories Recent Developments
    Table 102. Abbott Laboratories Company Details
    Table 103. Abbott Laboratories Business Overview
    Table 104. Abbott Laboratories Drugs of Bioengineered Protein Product
    Table 105. Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 106. Abbott Laboratories Recent Developments
    Table 107. Amgen Company Details
    Table 108. Amgen Business Overview
    Table 109. Amgen Drugs of Bioengineered Protein Product
    Table 110. Amgen Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 111. Amgen Recent Developments
    Table 112. Bayer AG Company Details
    Table 113. Bayer AG Business Overview
    Table 114. Bayer AG Drugs of Bioengineered Protein Product
    Table 115. Bayer AG Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 116. Bayer AG Recent Developments
    Table 117. Biocon Company Details
    Table 118. Biocon Business Overview
    Table 119. Biocon Drugs of Bioengineered Protein Product
    Table 120. Biocon Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 121. Biocon Recent Developments
    Table 122. Fresenius kabi Company Details
    Table 123. Fresenius kabi Business Overview
    Table 124. Fresenius kabi Drugs of Bioengineered Protein Product
    Table 125. Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 126. Fresenius kabi Recent Developments
    Table 127. Panacea Biotec Company Details
    Table 128. Panacea Biotec Business Overview
    Table 129. Panacea Biotec Drugs of Bioengineered Protein Product
    Table 130. Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2017-2022) & (US$ Million)
    Table 131. Panacea Biotec Recent Developments
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs of Bioengineered Protein Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Therapeutic Proteins Features
    Figure 4. Vaccines Features
    Figure 5. Global Drugs of Bioengineered Protein Market Share by Application: 2021 VS 2028
    Figure 6. Endocrinology Case Studies
    Figure 7. Immunology Case Studies
    Figure 8. Hematology Case Studies
    Figure 9. Infectiology Case Studies
    Figure 10. Neurology Case Studies
    Figure 11. Oncology Case Studies
    Figure 12. Genetic Disorder Case Studies
    Figure 13. Drugs of Bioengineered Protein Report Years Considered
    Figure 14. Global Drugs of Bioengineered Protein Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Drugs of Bioengineered Protein Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Drugs of Bioengineered Protein Market Share by Region: 2021 VS 2028
    Figure 17. Global Drugs of Bioengineered Protein Market Share by Players in 2021
    Figure 18. Global Top Drugs of Bioengineered Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2021
    Figure 20. North America Drugs of Bioengineered Protein Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Drugs of Bioengineered Protein Market Size Market Share by Type (2017-2028)
    Figure 22. North America Drugs of Bioengineered Protein Market Size Market Share by Application (2017-2028)
    Figure 23. North America Drugs of Bioengineered Protein Market Size Share by Country (2017-2028)
    Figure 24. United States Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Drugs of Bioengineered Protein Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Drugs of Bioengineered Protein Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Drugs of Bioengineered Protein Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Drugs of Bioengineered Protein Market Size Share by Country (2017-2028)
    Figure 30. Germany Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Drugs of Bioengineered Protein Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Drugs of Bioengineered Protein Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Drugs of Bioengineered Protein Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Drugs of Bioengineered Protein Market Size Share by Region (2017-2028)
    Figure 40. China Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Drugs of Bioengineered Protein Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Drugs of Bioengineered Protein Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Drugs of Bioengineered Protein Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Drugs of Bioengineered Protein Market Size Share by Country (2017-2028)
    Figure 50. Mexico Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Drugs of Bioengineered Protein Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Drugs of Bioengineered Protein Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Drugs of Bioengineered Protein Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Drugs of Bioengineered Protein Market Size Share by Country (2017-2028)
    Figure 56. Turkey Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Drugs of Bioengineered Protein Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 61. Merck Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 63. Sanofi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 64. Eli Lilly Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 65. Roche Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 66. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 67. Abbott Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 68. Amgen Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 69. Bayer AG Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 70. Biocon Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 71. Fresenius kabi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 72. Panacea Biotec Revenue Growth Rate in Drugs of Bioengineered Protein Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed